Brigham and Women's Hospital: A Teaching Affiliate of Harvard Medical School
TEXT SIZE: Increase Font Size / Decrease Font Size
Icon PrintPRINT
En EspanolESPAÑOL
Bookmark and Share
FIND A DOCTOR
REQUEST AN APPOINTMENT
  •  
  •  
    • History and Description
    • Locations and Directions
    • Innovative Care
    • News
    • Quality of Patient Care
    • Visiting BWH
    • Giving to BWH
    • Departments and Services
    • Contact Us
    • Careers
  •  

      CLINICAL DEPARTMENTS


    • Anesthesia
    • Cancer
    • Dermatology
    • Emergency Medicine
    • Medicine
    • Neurology
    • Neurosurgery
    • Newborn Medicine
    • Obstetrics and Gynecology
    • Orthopedic Surgery
    • Pathology
    • Psychiatry
    • Radiation Oncology
    • Radiology
    • Surgery
    • A to Z Listing of All Departments/Services

    • CENTERS OF EXCELLENCE


    • Cancer
    • Cardiovascular
    • Orthopedic and Arthritis
    • Neurosciences
    • Women's Health

      PATIENT CARE SERVICES


    • Care Coordination/ Social Work
    • Chaplaincy
    • Interpreter Services
    • Nursing
    • Nutrition
    • Patient and Family Relations
    • All Patient Care Services

  • Browse by Letter

    a
    b
    c
    d
    e
    f
    g
    h
    i
    j
    k
    l
    m
    n
    o
    p
    q
    r
    s
    t
    u
    v
    w
    x
    y
    z

    Specialty Areas

    • CANCER
    • HEART DISEASE
    • ORTHOPEDIC CONDITIONS
    • WOMEN'S HEALTH

    Search for Diseases
    and Conditions



  •  
    • Adult Health Library
    • En Español
    • Health Information Center
    • Interactive Tools and Media
    • Health News
    • Health Events
    • Health Publications
    • Video Center
    • BWH Kessler Library


  •  
    • Find a Doctor
    • Request an Appointment
    • Locations and Directions
    • Phone Numbers
    • Your Hospital Visit
    • Accessibility
    • Quality of Patient Care
    • Patient Gateway
    • Patient Resources
    • International Patients
    • Visitors


  •  

      RESEARCH AT BWH


    • About Research at BWH
    • BRI Centers and Programs
    • Find a Researcher
    • BRIefs
    • Departments
    • Laboratories and Research Projects
    • Research: Clinical

    • GET INVOLVED


    • Clinical Trials
    • Volunteer Opportunities

      FOR BWH RESEARCHERS


    • Biomedical Research Institute
    • Center for Clinical Investigation
    • Center for Faculty Development and Diversity
    • Cores and Resources
    • Office for Research Careers
    • Research Administration
    • Research Ventures and Licensing
  •  
    • Referring a Patient
    • Our Commitment to Quality
    • Educational Resources
    • Medical Community Events
    • BWH Residencies and Fellowships
    • Department of Nursing
    • Center for Nursing Excellence
    • Center for Faculty Development and Diversity
    • Center for Professionalism and Peer Support
Find A Researcher
  Previous  |  New Search  |  Return to Search Results  |  Next  

Frederick J. Schoen, MD, PhD


  View Physician Profile

Senior Pathologist, Brigham and Women's Hospital
Professor of Pathology and Health Sciences and Technology, Harvard Medical School
Executive Vice Chairman, Department of Pathology, Brigham and Women’s Hospital

Brigham and Women's Hospital
Department of Pathology
75 Francis Street
Boston, MA 02115



Research Narrative:

We investigate the functional structure and cell/matrix biology, and tissue engineering of heart valves. The objectives of these studies are to understand the mechanisms of normal valve functional dynamics and how these are disrupted in valve disease, and the limitations to the success of currently available prosthetic devices.  Our studies provide input to the development of improved management strategies for native and prosthetic valve disease and potentially new medical devices.

Specifically, we study healthy and diseased native heart valves and heart valve prostheses retrieved at reoperation or post-mortem examination.  Ongoing investigations of native valves explore the mechanisms of regulation of valvular interstitial cell phenotypes and collagenous matrix under various conditions of altered mechanical environment and patient age throughout life and approaches to the creation of a living valve replacement through in-vitro and in-vivo tissue engineering approaches based on an understanding of valve developmental biology, valvular cell and matrix biology and valve responses to injury.   Studies of valve substitutes are designed to establish failure modes, pathologic correlations of clinical function and other details of patient/prosthesis interactions.  In preclinical studies, we analyze new valve configurations with modified and potentially improved materials or designs implanted in animals as actual valve replacements in order to evaluate the long-term efficacy and safety of these designs, to predict complications, and to develop new materials and configurations.  We also study the mechanisms of particular failure modes associated with degeneration of bioprostheses in experimental animal model systems.  For example, our experimental studies of calcification, the major cause of failure of contemporary bioprosthetic valves, have provided the correlation of observations on human material with experimental data and hypotheses, delineating clinicopathologic correlates of failure, the role in calcification of key physiological variables and structural determinants.  We are also participating in the development of innovative heart valve replacements, including devices that can be implanted percutaneously through a catheter, and engineered tissue heart valves.  

Selected Publications

Rabkin-Aikawa E, Aikawa M, Farber, M, Kratz, JR, Garcia-Cardena G, Kouchoukos NT, Mitchell MB, Jonas RA, Schoen FJ:  Clinical pulmonary autograft valves: Pathological evidence of adaptive remodeling in the aortic site.  J Thorac Cardiovasc Surg. 2004; 128:552-562.

Sutherland FWH, Perry TE, Yu Y, Sherwood MC, Rabkin E, Masuda Y, Garcia GA, McLellan DL, Engelmayr GC, Sacks MS, Schoen FJ, Mayer JE.  From stem cells to viable autologous semilunar heart valve.  Circulation 2005; 111:2783-2791.

Schoen FJ, Levy RJ.  Calcification of tissue heart valve substitutes: progress toward understanding and prevention. Ann Thorac Surg 2005; 79:1072-1080.

Mendelson KM, Schoen FJ:  Heart valve tissue engineering: Concepts, approaches, progress, and challenges. Ann Biomed Engin 2006; 34:1799-1819.

Paruchuri S, Yang JH, Aikawa E, Melero-Martin JM, Khan ZA, Loukogeorgakis S, Schoen FJ, Bischoff J: Human pulmonary valve progenitor cells exhibit endothelial/mesenchymal plasticity in response to VEGF-A and TGFβ2.  Circ Res 2006; 99:861-869.

Aikawa E, Whittaker P, Farber M, Mendelson K, Padera RF, Aikawa M, Schoen FJ:  Human semilunar cardiac valve remodeling by activated cells from fetus to adult: Implications for postnatal adaptation, pathology and tissue engineering.  Circulation 2006; 113:1344-1352.

Mikos A, Herring SW, Elisseeff J, Lu HH, Kandel R, Schoen FJ, Toner M, Mooney D, Atala A, Kaplan DL, Vunjak-Novakovic G: Engineering complex tissues.  Tissue Eng, 2006, 12:3307-3339.

Schoen FJ.  Evolving concepts of cardiac valve dynamics.   The continuum of development, functional structure, pathobiology and tissue engineering.  Circulation (submitted)

Investigative Interests

Biomaterials-tissue interactions, medical devices and tissue engineering: cardiovascular pathology; CIMIT Site Miner at BWH

 
Education: PhD
MD
 
Keywords (MeSH): Heart Valve Prosthesis
Bioprosthesis
Calcinosis
Heart Valves
Heart Valve Diseases
 
Link to PubMed: View Schoen's Publications in PubMed.
 

Publications (Pulled from Harvard Catalyst Profiles):

1. Merryman WD, Schoen FJ. Mechanisms of calcification in aortic valve disease: role of mechanokinetics and mechanodynamics. Curr Cardiol Rep. 2013 May; 15(5):355.

2. Schoen FJ. 2013 society for cardiovascular pathology distinguished achievement award recipient - Michael a. Gimbrone, jr., m.d. Cardiovasc Pathol. 2013 Mar; 22(2):115-6.

3. Reichert WM, Harris TR, Lemons J, Mikos AG, Puleo DA, Schoen FJ, Temenoff JS. 2011 panel on developing a biomaterials curriculum. J Biomed Mater Res A. 2012 Mar; 100(3):802-16.

4. Schoen FJ. In memoriam: Jack L. Titus, M.D., Ph.D., 1926–2011. Cardiovasc Pathol. 2012 Jan-Feb; 21(1):62-4.

5. Rajamannan NM, Evans FJ, Aikawa E, Grande-Allen KJ, Demer LL, Heistad DD, Simmons CA, Masters KS, Mathieu P, O'Brien KD, Schoen FJ, Towler DA, Yoganathan AP, Otto CM. Calcific aortic valve disease: not simply a degenerative process: A review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Executive summary: Calcific aortic valve disease-2011 update. Circulation. 2011 Oct 18; 124(16):1783-91.

6. Schoen FJ. Mechanisms of function and disease of natural and replacement heart valves. Annu Rev Pathol. 2012; 7:161-83.

7. Connolly JM, Bakay MA, Alferiev IS, Gorman RC, Gorman JH, Kruth HS, Ashworth PE, Kutty JK, Schoen FJ, Bianco RW, Levy RJ. Triglycidyl amine crosslinking combined with ethanol inhibits bioprosthetic heart valve calcification. Ann Thorac Surg. 2011 Sep; 92(3):858-65.

8. Schoen FJ. Heart valve tissue engineering: quo vadis? Curr Opin Biotechnol. 2011 Oct; 22(5):698-705.

9. Eckert CE, Mikulis BT, Gottlieb D, Gerneke D, LeGrice I, Padera RF, Mayer JE, Schoen FJ, Sacks MS. Three-dimensional quantitative micromorphology of pre- and post-implanted engineered heart valve tissues. Ann Biomed Eng. 2011 Jan; 39(1):205-22.

10. Braunlin E, Tolar J, Mackey-Bojack S, Masinde T, Krivit W, Schoen FJ. Clear cells in the atrioventricular valves of infants with severe human mucopolysaccharidosis (Hurler syndrome) are activated valvular interstitial cells. Cardiovasc Pathol. 2011 Sep-Oct; 20(5):315-21.

show all
11. Schoen FJ. Introduction to congenital heart disease articles in Cardiovascular Pathology. Cardiovasc Pathol. 2010 Sep-Oct; 19(5):257-8.

12. Schoen FJ. Cardiovascular pathology: maturation of a discipline and the Society for Cardiovascular Pathology. Cardiovasc Pathol. 2010 Jul-Aug; 19(4):198-200.

13. Weinberg EJ, Mack PJ, Schoen FJ, García-Cardeña G, Kaazempur Mofrad MR. Hemodynamic environments from opposing sides of human aortic valve leaflets evoke distinct endothelial phenotypes in vitro. Cardiovasc Eng. 2010 Mar; 10(1):5-11.

14. Thiene G, Veinot JP, Angelini A, Baandrup UT, Basso C, Bruneval P, Buja LM, Butany J, d'Amati G, de Gouveia RH, Fallon JT, Fishbein MC, Gallagher PJ, Kholova I, Leone O, McManus B, Rodriguez ER, Schoen FJ, Sheppard MN, Stone JR, van der Wal AC, Winters GL. AECVP and SCVP 2009 recommendations for training in cardiovascular pathology. Cardiovasc Pathol. 2010 May-Jun; 19(3):129-35.

15. Sales VL, Mettler BA, Engelmayr GC, Aikawa E, Bischoff J, Martin DP, Exarhopoulos A, Moses MA, Schoen FJ, Sacks MS, Mayer JE. Endothelial progenitor cells as a sole source for ex vivo seeding of tissue-engineered heart valves. Tissue Eng Part A. 2010 Jan; 16(1):257-67.

16. Schoen FJ, Levy RJ. SnapShot: calcification of bioprosthetic heart valves. Biomaterials. 2009 Sep; 30(26):4445-6.

17. Weinberg EJ, Schoen FJ, Mofrad MR. A computational model of aging and calcification in the aortic heart valve. PLoS One. 2009; 4(6):e5960.

18. Joyce EM, Liao J, Schoen FJ, Mayer JE, Sacks MS. Functional collagen fiber architecture of the pulmonary heart valve cusp. Ann Thorac Surg. 2009 Apr; 87(4):1240-9.

19. Sacks MS, Schoen FJ, Mayer JE. Bioengineering challenges for heart valve tissue engineering. Annu Rev Biomed Eng. 2009; 11:289-313.

20. Schoen FJ. Evolving concepts of cardiac valve dynamics: the continuum of development, functional structure, pathobiology, and tissue engineering. Circulation. 2008 Oct 28; 118(18):1864-80.

21. Lucas JA, Menke J, Rabacal WA, Schoen FJ, Sharpe AH, Kelley VR. Programmed death ligand 1 regulates a critical checkpoint for autoimmune myocarditis and pneumonitis in MRL mice. J Immunol. 2008 Aug 15; 181(4):2513-21.

22. Chu TF, Rupnick MA, Kerkela R, Dallabrida SM, Zurakowski D, Nguyen L, Woulfe K, Pravda E, Cassiola F, Desai J, George S, Morgan JA, Harris DM, Ismail NS, Chen JH, Schoen FJ, Van den Abbeele AD, Demetri GD, Force T, Chen MH. Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib. Lancet. 2007 Dec 15; 370(9604):2011-9.

23. Mendelson K, Aikawa E, Mettler BA, Sales V, Martin D, Mayer JE, Schoen FJ. Healing and remodeling of bioengineered pulmonary artery patches implanted in sheep. Cardiovasc Pathol. 2007 Sep-Oct; 16(5):277-82.

24. Mikos AG, Herring SW, Ochareon P, Elisseeff J, Lu HH, Kandel R, Schoen FJ, Toner M, Mooney D, Atala A, Van Dyke ME, Kaplan D, Vunjak-Novakovic G. Engineering complex tissues. Tissue Eng. 2006 Dec; 12(12):3307-39.

25. Mendelson K, Schoen FJ. Heart valve tissue engineering: concepts, approaches, progress, and challenges. Ann Biomed Eng. 2006 Dec; 34(12):1799-819.

26. Paruchuri S, Yang JH, Aikawa E, Melero-Martin JM, Khan ZA, Loukogeorgakis S, Schoen FJ, Bischoff J. Human pulmonary valve progenitor cells exhibit endothelial/mesenchymal plasticity in response to vascular endothelial growth factor-A and transforming growth factor-beta2. Circ Res. 2006 Oct 13; 99(8):861-9.

27. Schoen FJ. New frontiers in the pathology and therapy of heart valve disease: 2006 Society for Cardiovascular Pathology, Distinguished Achievement Award Lecture, United States-Canadian Academy of Pathology, Atlanta, GA, February 12, 2006. Cardiovasc Pathol. 2006 Sep-Oct; 15(5):271-9.

28. Hoerstrup SP, Cummings Mrcs I, Lachat M, Schoen FJ, Jenni R, Leschka S, Neuenschwander S, Schmidt D, Mol A, Günter C, Gössi M, Genoni M, Zund G. Functional growth in tissue-engineered living, vascular grafts: follow-up at 100 weeks in a large animal model. Circulation. 2006 Jul 4; 114(1 Suppl):I159-66.

29. Aikawa E, Whittaker P, Farber M, Mendelson K, Padera RF, Aikawa M, Schoen FJ. Human semilunar cardiac valve remodeling by activated cells from fetus to adult: implications for postnatal adaptation, pathology, and tissue engineering. Circulation. 2006 Mar 14; 113(10):1344-52.

30. Thiene G, Becker AE, Buja LM, Fallon JT, McManus BM, Schoen FJ, Winters GL. Toward a cardiovascular pathology training report on the forum held in Vancouver, March 6, 2004, Society for Cardiovascular Pathology. Cardiovasc Pathol. 2005 Nov-Dec; 14(6):312-9.

31. Larose E, Yeghiazarians Y, Libby P, Yucel EK, Aikawa M, Kacher DF, Aikawa E, Kinlay S, Schoen FJ, Selwyn AP, Ganz P. Characterization of human atherosclerotic plaques by intravascular magnetic resonance imaging. Circulation. 2005 Oct 11; 112(15):2324-31.

32. Schoen FJ. Cardiac valves and valvular pathology: update on function, disease, repair, and replacement. Cardiovasc Pathol. 2005 Jul-Aug; 14(4):189-94.

33. Sutherland FW, Perry TE, Yu Y, Sherwood MC, Rabkin E, Masuda Y, Garcia GA, McLellan DL, Engelmayr GC, Sacks MS, Schoen FJ, Mayer JE. From stem cells to viable autologous semilunar heart valve. Circulation. 2005 May 31; 111(21):2783-91.

34. Arany Z, He H, Lin J, Hoyer K, Handschin C, Toka O, Ahmad F, Matsui T, Chin S, Wu PH, Rybkin II, Shelton JM, Manieri M, Cinti S, Schoen FJ, Bassel-Duby R, Rosenzweig A, Ingwall JS, Spiegelman BM. Transcriptional coactivator PGC-1 alpha controls the energy state and contractile function of cardiac muscle. Cell Metab. 2005 Apr; 1(4):259-71.

35. Schoen FJ, Levy RJ. Calcification of tissue heart valve substitutes: progress toward understanding and prevention. Ann Thorac Surg. 2005 Mar; 79(3):1072-80.

36. He Z, Way KJ, Arikawa E, Chou E, Opland DM, Clermont A, Isshiki K, Ma RC, Scott JA, Schoen FJ, Feener EP, King GL. Differential regulation of angiotensin II-induced expression of connective tissue growth factor by protein kinase C isoforms in the myocardium. J Biol Chem. 2005 Apr 22; 280(16):15719-26.

37. Merryman WD, Huang HY, Schoen FJ, Sacks MS. The effects of cellular contraction on aortic valve leaflet flexural stiffness. J Biomech. 2006; 39(1):88-96.

38. Rabkin-Aikawa E, Mayer JE, Schoen FJ. Heart valve regeneration. Adv Biochem Eng Biotechnol. 2005; 94:141-79.

39. Engelmayr GC, Rabkin E, Sutherland FW, Schoen FJ, Mayer JE, Sacks MS. The independent role of cyclic flexure in the early in vitro development of an engineered heart valve tissue. Biomaterials. 2005 Jan; 26(2):175-87.

40. Radisic M, Park H, Shing H, Consi T, Schoen FJ, Langer R, Freed LE, Vunjak-Novakovic G. Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc Natl Acad Sci U S A. 2004 Dec 28; 101(52):18129-34.

41. Breuer CK, Mettler BA, Anthony T, Sales VL, Schoen FJ, Mayer JE. Application of tissue-engineering principles toward the development of a semilunar heart valve substitute. Tissue Eng. 2004 Nov-Dec; 10(11-12):1725-36.

42. Rabkin-Aikawa E, Aikawa M, Farber M, Kratz JR, Garcia-Cardena G, Kouchoukos NT, Mitchell MB, Jonas RA, Schoen FJ. Clinical pulmonary autograft valves: pathologic evidence of adaptive remodeling in the aortic site. J Thorac Cardiovasc Surg. 2004 Oct; 128(4):552-61.

43. Fukumoto Y, Deguchi JO, Libby P, Rabkin-Aikawa E, Sakata Y, Chin MT, Hill CC, Lawler PR, Varo N, Schoen FJ, Krane SM, Aikawa M. Genetically determined resistance to collagenase action augments interstitial collagen accumulation in atherosclerotic plaques. Circulation. 2004 Oct 5; 110(14):1953-9.

44. Rabkin-Aikawa E, Farber M, Aikawa M, Schoen FJ. Dynamic and reversible changes of interstitial cell phenotype during remodeling of cardiac valves. J Heart Valve Dis. 2004 Sep; 13(5):841-7.

45. Hamner C, Ruth G, Raffe M, Schoen FJ, Schaff H. Safety and biocompatibility of the Myosplint system--a passive implantable device that alters ventricular geometry for the treatment of heart failure. ASAIO J. 2004 Sep-Oct; 50(5):438-43.

46. Wu X, Rabkin-Aikawa E, Guleserian KJ, Perry TE, Masuda Y, Sutherland FW, Schoen FJ, Mayer JE, Bischoff J. Tissue-engineered microvessels on three-dimensional biodegradable scaffolds using human endothelial progenitor cells. Am J Physiol Heart Circ Physiol. 2004 Aug; 287(2):H480-7.

47. Levy RJ, Vyavahare N, Ogle M, Ashworth P, Bianco R, Schoen FJ. Inhibition of cusp and aortic wall calcification in ethanol- and aluminum-treated bioprosthetic heart valves in sheep: background, mechanisms, and synergism. J Heart Valve Dis. 2003 Mar; 12(2):209-16; discussion 216.

48. Sacks MS, Schoen FJ. Collagen fiber disruption occurs independent of calcification in clinically explanted bioprosthetic heart valves. J Biomed Mater Res. 2002 Dec 5; 62(3):359-71.

49. Johnson EN, Lee YM, Sander TL, Rabkin E, Schoen FJ, Kaushal S, Bischoff J. NFATc1 mediates vascular endothelial growth factor-induced proliferation of human pulmonary valve endothelial cells. J Biol Chem. 2003 Jan 17; 278(3):1686-92.

50. Rabkin E, Schoen FJ. Cardiovascular tissue engineering. Cardiovasc Pathol. 2002 Nov-Dec; 11(6):305-17.

51. Aikawa M, Sugiyama S, Hill CC, Voglic SJ, Rabkin E, Fukumoto Y, Schoen FJ, Witztum JL, Libby P. Lipid lowering reduces oxidative stress and endothelial cell activation in rabbit atheroma. Circulation. 2002 Sep 10; 106(11):1390-6.

52. Way KJ, Isshiki K, Suzuma K, Yokota T, Zvagelsky D, Schoen FJ, Sandusky GE, Pechous PA, Vlahos CJ, Wakasaki H, King GL. Expression of connective tissue growth factor is increased in injured myocardium associated with protein kinase C beta2 activation and diabetes. Diabetes. 2002 Sep; 51(9):2709-18.

53. Carrier RL, Rupnick M, Langer R, Schoen FJ, Freed LE, Vunjak-Novakovic G. Effects of oxygen on engineered cardiac muscle. Biotechnol Bioeng. 2002 Jun 20; 78(6):617-25.

54. Rabkin E, Hoerstrup SP, Aikawa M, Mayer JE, Schoen FJ. Evolution of cell phenotype and extracellular matrix in tissue-engineered heart valves during in-vitro maturation and in-vivo remodeling. J Heart Valve Dis. 2002 May; 11(3):308-14; discussion 314.

55. Carrier RL, Rupnick M, Langer R, Schoen FJ, Freed LE, Vunjak-Novakovic G. Perfusion improves tissue architecture of engineered cardiac muscle. Tissue Eng. 2002 Apr; 8(2):175-88.

56. Lindsey ML, Gannon J, Aikawa M, Schoen FJ, Rabkin E, Lopresti-Morrow L, Crawford J, Black S, Libby P, Mitchell PG, Lee RT. Selective matrix metalloproteinase inhibition reduces left ventricular remodeling but does not inhibit angiogenesis after myocardial infarction. Circulation. 2002 Feb 12; 105(6):753-8.

57. Rabkin E, Aikawa M, Stone JR, Fukumoto Y, Libby P, Schoen FJ. Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves. Circulation. 2001 Nov 20; 104(21):2525-32.

58. Paranya G, Vineberg S, Dvorin E, Kaushal S, Roth SJ, Rabkin E, Schoen FJ, Bischoff J. Aortic valve endothelial cells undergo transforming growth factor-beta-mediated and non-transforming growth factor-beta-mediated transdifferentiation in vitro. Am J Pathol. 2001 Oct; 159(4):1335-43.

59. Kaushal S, Amiel GE, Guleserian KJ, Shapira OM, Perry T, Sutherland FW, Rabkin E, Moran AM, Schoen FJ, Atala A, Soker S, Bischoff J, Mayer JE. Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat Med. 2001 Sep; 7(9):1035-40.

60. Mende U, Semsarian C, Martins DC, Kagen A, Duffy C, Schoen FJ, Neer EJ. Dilated cardiomyopathy in two transgenic mouse lines expressing activated G protein alpha(q): lack of correlation between phospholipase C activation and the phenotype. J Mol Cell Cardiol. 2001 Aug; 33(8):1477-91.

61. Jian B, Jones PL, Li Q, Mohler ER, Schoen FJ, Levy RJ. Matrix metalloproteinase-2 is associated with tenascin-C in calcific aortic stenosis. Am J Pathol. 2001 Jul; 159(1):321-7.

62. Schoen FJ. Editorial: Are immune mechanisms important in tissue heart valve failure? A debate. J Heart Valve Dis. 2001 Jul; 10(4):458-9.

63. Schoen FJ, Gimbrone MA. Ramzi S. Cotran, M.D., 1932-2000. Cardiovasc Pathol. 2001 May-Jun; 10(3):107-8.

64. McConnell BK, Fatkin D, Semsarian C, Jones KA, Georgakopoulos D, Maguire CT, Healey MJ, Mudd JO, Moskowitz IP, Conner DA, Giewat M, Wakimoto H, Berul CI, Schoen FJ, Kass DA, Seidman CE, Seidman JG. Comparison of two murine models of familial hypertrophic cardiomyopathy. Circ Res. 2001 Mar 2; 88(4):383-9.

65. Aikawa M, Rabkin E, Sugiyama S, Voglic SJ, Fukumoto Y, Furukawa Y, Shiomi M, Schoen FJ, Libby P. An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro. Circulation. 2001 Jan 16; 103(2):276-83.

66. Fatkin D, McConnell BK, Mudd JO, Semsarian C, Moskowitz IG, Schoen FJ, Giewat M, Seidman CE, Seidman JG. An abnormal Ca(2+) response in mutant sarcomere protein-mediated familial hypertrophic cardiomyopathy. J Clin Invest. 2000 Dec; 106(11):1351-9.

67. Stock UA, Sakamoto T, Hatsuoka S, Martin DP, Nagashima M, Moran AM, Moses MA, Khalil PN, Schoen FJ, Vacanti JP, Mayer JE. Patch augmentation of the pulmonary artery with bioabsorbable polymers and autologous cell seeding. J Thorac Cardiovasc Surg. 2000 Dec; 120(6):1158-67; discussion 1168.

68. Sodian R, Hoerstrup SP, Sperling JS, Daebritz S, Martin DP, Moran AM, Kim BS, Schoen FJ, Vacanti JP, Mayer JE. Early in vivo experience with tissue-engineered trileaflet heart valves. Circulation. 2000 Nov 7; 102(19 Suppl 3):III22-9.

69. Hoerstrup SP, Sodian R, Daebritz S, Wang J, Bacha EA, Martin DP, Moran AM, Guleserian KJ, Sperling JS, Kaushal S, Vacanti JP, Schoen FJ, Mayer JE. Functional living trileaflet heart valves grown in vitro. Circulation. 2000 Nov 7; 102(19 Suppl 3):III44-9.

70. Laufs U, Endres M, Stagliano N, Amin-Hanjani S, Chui DS, Yang SX, Simoncini T, Yamada M, Rabkin E, Allen PG, Huang PL, Böhm M, Schoen FJ, Moskowitz MA, Liao JK. Neuroprotection mediated by changes in the endothelial actin cytoskeleton. J Clin Invest. 2000 Jul; 106(1):15-24.

71. Ducharme A, Frantz S, Aikawa M, Rabkin E, Lindsey M, Rohde LE, Schoen FJ, Kelly RA, Werb Z, Libby P, Lee RT. Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J Clin Invest. 2000 Jul; 106(1):55-62.

72. Sodian R, Hoerstrup SP, Sperling JS, Daebritz SH, Martin DP, Schoen FJ, Vacanti JP, Mayer JE. Tissue engineering of heart valves: in vitro experiences. Ann Thorac Surg. 2000 Jul; 70(1):140-4.

73. Vyavahare NR, Jones PL, Hirsch D, Schoen FJ, Levy RJ. Prevention of glutaraldehyde-fixed bioprosthetic heart valve calcification by alcohol pretreatment: further mechanistic studies. J Heart Valve Dis. 2000 Jul; 9(4):561-6.

74. Vaughan CJ, Weremowicz S, Goldstein MM, Casey M, Hart M, Hahn RT, Devereux RB, Girardi L, Schoen FJ, Fletcher JA, Morton CC, Basson CT. A t(2;19)(p13;p13.2) in a giant invasive cardiac lipoma from a patient with multiple lipomatosis. Genes Chromosomes Cancer. 2000 Jun; 28(2):133-7.

75. Stock UA, Nagashima M, Khalil PN, Nollert GD, Herden T, Sperling JS, Moran A, Lien J, Martin DP, Schoen FJ, Vacanti JP, Mayer JE. Tissue-engineered valved conduits in the pulmonary circulation. J Thorac Cardiovasc Surg. 2000 Apr; 119(4 Pt 1):732-40.

76. VanderBrink BA, Gilbride C, Aronovitz MJ, Lenihan T, Schorn G, Taylor K, Regan JF, Carr K, Schoen FJ, Link MS, Homoud MK, Estes NA, Wang PJ. Safety and efficacy of a steerable temperature monitoring microwave catheter system for ventricular myocardial ablation. J Cardiovasc Electrophysiol. 2000 Mar; 11(3):305-10.

77. Mueller J, Schoen F, Helms J. Bilateral cochlear implant--new aspects for the future? Adv Otorhinolaryngol. 2000; 57:22-7.

78. Knaus C, Mueller J, Schoen F. A novel outer ear canal electrode for noninvasive electrical stimulation of the cochlear nerve in preoperative evaluation for cochlear implants in adults and children. Adv Otorhinolaryngol. 2000; 57:152-6.

79. Schoen FJ, Levy RJ. Founder's Award, 25th Annual Meeting of the Society for Biomaterials, perspectives. Providence, RI, April 28-May 2, 1999. Tissue heart valves: current challenges and future research perspectives. J Biomed Mater Res. 1999 Dec 15; 47(4):439-65.

80. McConnell BK, Jones KA, Fatkin D, Arroyo LH, Lee RT, Aristizabal O, Turnbull DH, Georgakopoulos D, Kass D, Bond M, Niimura H, Schoen FJ, Conner D, Fischman DA, Seidman CE, Seidman JG. Dilated cardiomyopathy in homozygous myosin-binding protein-C mutant mice J Clin Invest. 1999 Dec; 104(12):1771.

81. Koya D, Dennis JW, Warren CE, Takahara N, Schoen FJ, Nishio Y, Nakajima T, Lipes MA, King GL. Overexpression of core 2 N-acetylglycosaminyltransferase enhances cytokine actions and induces hypertrophic myocardium in transgenic mice. FASEB J. 1999 Dec; 13(15):2329-37.

82. McConnell BK, Jones KA, Fatkin D, Arroyo LH, Lee RT, Aristizabal O, Turnbull DH, Georgakopoulos D, Kass D, Bond M, Niimura H, Schoen FJ, Conner D, Fischman DA, Seidman CE, Seidman JG, Fischman DH. Dilated cardiomyopathy in homozygous myosin-binding protein-C mutant mice. J Clin Invest. 1999 Nov; 104(9):1235-44.

83. Podolsky SH, Zembowicz A, Schoen FJ, Benjamin RJ, Sonna LA. Massive myocardial necrosis in thrombotic thrombocytopenic purpura: a case report and review of the literature. Arch Pathol Lab Med. 1999 Oct; 123(10):937-40.

84. Fyfe BS, Schoen FJ. Pathological analysis of nonstented Freestyle aortic root bioprostheses treated with amino oleic acid. Semin Thorac Cardiovasc Surg. 1999 Oct; 11(4 Suppl 1):151-6.

85. Carrier RL, Papadaki M, Rupnick M, Schoen FJ, Bursac N, Langer R, Freed LE, Vunjak-Novakovic G. Cardiac tissue engineering: cell seeding, cultivation parameters, and tissue construct characterization. Biotechnol Bioeng. 1999 Sep 5; 64(5):580-9.

86. Vyavahare N, Ogle M, Schoen FJ, Levy RJ. Elastin calcification and its prevention with aluminum chloride pretreatment. Am J Pathol. 1999 Sep; 155(3):973-82.

87. Bursac N, Papadaki M, Cohen RJ, Schoen FJ, Eisenberg SR, Carrier R, Vunjak-Novakovic G, Freed LE. Cardiac muscle tissue engineering: toward an in vitro model for electrophysiological studies. Am J Physiol. 1999 Aug; 277(2 Pt 2):H433-44.

88. Bini A, Mann KG, Kudryk BJ, Schoen FJ. Noncollagenous bone matrix proteins, calcification, and thrombosis in carotid artery atherosclerosis. Arterioscler Thromb Vasc Biol. 1999 Aug; 19(8):1852-61.

89. Vyavahare N, Ogle M, Schoen FJ, Zand R, Gloeckner DC, Sacks M, Levy RJ. Mechanisms of bioprosthetic heart valve failure: fatigue causes collagen denaturation and glycosaminoglycan loss. J Biomed Mater Res. 1999 Jul; 46(1):44-50.

90. Schoen FJ. Future directions in tissue heart valves: impact of recent insights from biology and pathology. J Heart Valve Dis. 1999 Jul; 8(4):350-8.

91. Vargas SO, Sampson BA, Schoen FJ. Pathologic detection of early myocardial infarction: a critical review of the evolution and usefulness of modern techniques. Mod Pathol. 1999 Jun; 12(6):635-45.

92. Sukhova GK, Schönbeck U, Rabkin E, Schoen FJ, Poole AR, Billinghurst RC, Libby P. Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. Circulation. 1999 May 18; 99(19):2503-9.

93. Fatkin D, Christe ME, Aristizabal O, McConnell BK, Srinivasan S, Schoen FJ, Seidman CE, Turnbull DH, Seidman JG. Neonatal cardiomyopathy in mice homozygous for the Arg403Gln mutation in the alpha cardiac myosin heavy chain gene. J Clin Invest. 1999 Jan; 103(1):147-53.

94. Schoen FJ. Collaboration between the Society for Cardiovascular Pathology (SCVP) and the International Society for Applied Cardiovascular Biology (ISACB) is justified. Cardiovasc Pathol. 1999 Jan-Feb; 8(1):53-4.

95. Topper JN, Cai J, Stavrakis G, Anderson KR, Woolf EA, Sampson BA, Schoen FJ, Falb D, Gimbrone MA. Human prostaglandin transporter gene (hPGT) is regulated by fluid mechanical stimuli in cultured endothelial cells and expressed in vascular endothelium in vivo. Circulation. 1998 Dec 1; 98(22):2396-403.

96. Aikawa M, Rabkin E, Voglic SJ, Shing H, Nagai R, Schoen FJ, Libby P. Lipid lowering promotes accumulation of mature smooth muscle cells expressing smooth muscle myosin heavy chain isoforms in rabbit atheroma. Circ Res. 1998 Nov 16; 83(10):1015-26.

97. Mende U, Kagen A, Cohen A, Aramburu J, Schoen FJ, Neer EJ. Transient cardiac expression of constitutively active Galphaq leads to hypertrophy and dilated cardiomyopathy by calcineurin-dependent and independent pathways. Proc Natl Acad Sci U S A. 1998 Nov 10; 95(23):13893-8.

98. Lee CH, Vyavahare N, Zand R, Kruth H, Schoen FJ, Bianco R, Levy RJ. Inhibition of aortic wall calcification in bioprosthetic heart valves by ethanol pretreatment: biochemical and biophysical mechanisms. J Biomed Mater Res. 1998 Oct; 42(1):30-7.

99. Vyavahare NR, Hirsch D, Lerner E, Baskin JZ, Zand R, Schoen FJ, Levy RJ. Prevention of calcification of glutaraldehyde-crosslinked porcine aortic cusps by ethanol preincubation: mechanistic studies of protein structure and water-biomaterial relationships. J Biomed Mater Res. 1998 Jun 15; 40(4):577-85.

100. Schoen FJ. Pathologic findings in explanted clinical bioprosthetic valves fabricated from photooxidized bovine pericardium. J Heart Valve Dis. 1998 Mar; 7(2):174-9.

101. Mesana TG, Mouly-Bandini A, Ferzoco SJ, Collart F, Caus T, Reul RM, Monties JR, Schoen FJ, Cohn LH. Dynamic aortomyoplasty: clinical experience and thoracoscopic surgery feasibility study. J Card Surg. 1998 Jan; 13(1):60-9.

102. Mitchell RN, Jonas RA, Schoen FJ. Pathology of explanted cryopreserved allograft heart valves: comparison with aortic valves from orthotopic heart transplants. J Thorac Cardiovasc Surg. 1998 Jan; 115(1):118-27.

103. Blanchard EM, Iizuka K, Christe M, Conner DA, Geisterfer-Lowrance A, Schoen FJ, Maughan DW, Seidman CE, Seidman JG. Targeted ablation of the murine alpha-tropomyosin gene. Circ Res. 1997 Dec; 81(6):1005-10.

104. Winters GL, Schoen FJ. Graft arteriosclerosis-induced myocardial pathology in heart transplant recipients: predictive value of endomyocardial biopsy. J Heart Lung Transplant. 1997 Oct; 16(10):985-93.

105. Mesana TG, Ferzoco SJ, Reul RM, Sayeed-Shah U, Karamichalis JM, Laurence RG, Schoen FJ, Cohn LH. Innovative techniques in skeletal muscle cardiac assistance: first experimental study on minimally invasive aortomyoplasty and cardiomyoplasty. ASAIO J. 1997 Sep-Oct; 43(5):M791-6.

106. Mason DP, Orgill DP, Schoen FJ, Rizzo RJ. Traumatic carotid artery dissection of restrained driver and thoracic aorta transection of unrestrained passenger in a motor vehicle accident: case report. J Trauma. 1997 Sep; 43(3):537-40.

107. Wakasaki H, Koya D, Schoen FJ, Jirousek MR, Ways DK, Hoit BD, Walsh RA, King GL. Targeted overexpression of protein kinase C beta2 isoform in myocardium causes cardiomyopathy. Proc Natl Acad Sci U S A. 1997 Aug 19; 94(17):9320-5.

108. Topper JN, Cai J, Qiu Y, Anderson KR, Xu YY, Deeds JD, Feeley R, Gimeno CJ, Woolf EA, Tayber O, Mays GG, Sampson BA, Schoen FJ, Gimbrone MA, Falb D. Vascular MADs: two novel MAD-related genes selectively inducible by flow in human vascular endothelium. Proc Natl Acad Sci U S A. 1997 Aug 19; 94(17):9314-9.

109. Gott JP, Girardot MN, Girardot JM, Hall JD, Whitlark JD, Horsley WS, Dorsey LM, Levy RJ, Chen W, Schoen FJ, Guyton RA. Refinement of the alpha aminooleic acid bioprosthetic valve anticalcification technique. Ann Thorac Surg. 1997 Jul; 64(1):50-8.

110. Biedrzycki LM, Lerner E, Levy RJ, Schoen FJ. Differential calcification of cusps and aortic wall of failed stented porcine bioprosthetic valves. J Biomed Mater Res. 1997 Mar 15; 34(4):411-5.

111. Coviello DA, Maron BJ, Spirito P, Watkins H, Vosberg HP, Thierfelder L, Schoen FJ, Seidman JG, Seidman CE. Clinical features of hypertrophic cardiomyopathy caused by mutation of a "hot spot" in the alpha-tropomyosin gene. J Am Coll Cardiol. 1997 Mar 1; 29(3):635-40.

112. Vyavahare N, Hirsch D, Lerner E, Baskin JZ, Schoen FJ, Bianco R, Kruth HS, Zand R, Levy RJ. Prevention of bioprosthetic heart valve calcification by ethanol preincubation. Efficacy and mechanisms. Circulation. 1997 Jan 21; 95(2):479-88.

113. Chen W, Schoen FJ, Myers DJ, Levy RJ. Synergistic inhibition of calcification of porcine aortic root with preincubation in FeCl3 and alpha-amino oleic acid in a rat subdermal model. J Biomed Mater Res. 1997; 38(1):43-8.

114. Edmunds LH, Mckinlay S, Anderson JM, Callahan TH, Chesebro JH, Geiser EA, Makanani DM, McIntire LV, Meeker WQ, Naughton GK, Panza JA, Schoen FJ, Didisheim P. Directions for improvement of substitute heart valves: National Heart, Lung, and Blood Institute's Working Group report on heart valves. J Biomed Mater Res. 1997; 38(3):263-6.

115. Schoen FJ. Aortic valve structure-function correlations: role of elastic fibers no longer a stretch of the imagination. J Heart Valve Dis. 1997 Jan; 6(1):1-6.

116. Behar O, Golden JA, Mashimo H, Schoen FJ, Fishman MC. Semaphorin III is needed for normal patterning and growth of nerves, bones and heart. Nature. 1996 Oct 10; 383(6600):525-8.

117. Lee RT, Schoen FJ, Loree HM, Lark MW, Libby P. Circumferential stress and matrix metalloproteinase 1 in human coronary atherosclerosis. Implications for plaque rupture. Arterioscler Thromb Vasc Biol. 1996 Aug; 16(8):1070-3.

118. Stamler A, Wang SY, Li J, Thurer RL, Schoen FJ, Sellke FW. Moderate hypothermia reduces cardiopulmonary bypass-induced impairment of cerebrovascular responses to platelet products. Ann Thorac Surg. 1996 Jul; 62(1):191-8.

119. Joshi RR, Underwood T, Frautschi JR, Phillips RE, Schoen FJ, Levy RJ. Calcification of polyurethanes implanted subdermally in rats is enhanced by calciphylaxis. J Biomed Mater Res. 1996 Jun; 31(2):201-7.

120. Geisterfer-Lowrance AA, Christe M, Conner DA, Ingwall JS, Schoen FJ, Seidman CE, Seidman JG. A mouse model of familial hypertrophic cardiomyopathy. Science. 1996 May 3; 272(5262):731-4.

121. Fyfe B, Loh E, Winters GL, Couper GS, Kartashov AI, Schoen FJ. Heart transplantation-associated perioperative ischemic myocardial injury. Morphological features and clinical significance. Circulation. 1996 Mar 15; 93(6):1133-40.

122. Tanaka H, Swanson SJ, Sukhova G, Schoen FJ, Libby P. Smooth muscle cells of the coronary arterial tunica media express tumor necrosis factor-alpha and proliferate during acute rejection of rabbit cardiac allografts. Am J Pathol. 1995 Sep; 147(3):617-26.

123. Nakagawa T, Sukhova GK, Rabkin E, Winters GL, Schoen FJ, Libby P. Acute rejection accelerates graft coronary disease in transplanted rabbit hearts. Circulation. 1995 Aug 15; 92(4):987-93.

124. Mitchell RN, Jonas RA, Schoen FJ. Structure-function correlations in cryopreserved allograft cardiac valves. Ann Thorac Surg. 1995 Aug; 60(2 Suppl):S108-12; discussion S113.

125. Tomazic BB, Edwards WD, Schoen FJ. Physicochemical characterization of natural and bioprosthetic heart valve calcific deposits: implications for prevention. Ann Thorac Surg. 1995 Aug; 60(2 Suppl):S322-7.

126. Schoen FJ, Mitchell RN, Jonas RA. Pathological considerations in cryopreserved allograft heart valves. J Heart Valve Dis. 1995 Jul; 4 Suppl 1:S72-5; discussion S75-6.

127. Tanaka H, Swanson SJ, Sukhova G, Schoen FJ, Libby P. Early proliferation of medial smooth muscle cells in coronary arteries of rabbit cardiac allografts during immunosuppression with cyclosporine A. Transplant Proc. 1995 Jun; 27(3):2062-5.

128. Winters GL, Loh E, Schoen FJ. Natural history of focal moderate cardiac allograft rejection. Is treatment warranted? Circulation. 1995 Apr 1; 91(7):1975-80.

129. Levy RJ, Qu X, Underwood T, Trachy J, Schoen FJ. Calcification of valved aortic allografts in rats: effects of age, crosslinking, and inhibitors. J Biomed Mater Res. 1995 Feb; 29(2):217-26.

130. Briscoe DM, Yeung AC, Schoen FJ, Allred EN, Stavrakis G, Ganz P, Cotran RS, Pober JS, Schoen EL. Predictive value of inducible endothelial cell adhesion molecule expression for acute rejection of human cardiac allografts. Transplantation. 1995 Jan 27; 59(2):204-11.

131. Horvath KA, Smith WJ, Laurence RG, Schoen FJ, Appleyard RF, Cohn LH. Recovery and viability of an acute myocardial infarct after transmyocardial laser revascularization. J Am Coll Cardiol. 1995 Jan; 25(1):258-63.

132. Schoen FJ. Pathologic considerations in replacement heart valves and other cardiovascular prosthetic devices. Monogr Pathol. 1995; 37:194-222.

133. Chen W, Kim JD, Schoen FJ, Levy RJ. Effect of 2-amino oleic acid exposure conditions on the inhibition of calcification of glutaraldehyde cross-linked porcine aortic valves. J Biomed Mater Res. 1994 Dec; 28(12):1485-95.

134. Schoen FJ, Hirsch D, Bianco RW, Levy RJ. Onset and progression of calcification in porcine aortic bioprosthetic valves implanted as orthotopic mitral valve replacements in juvenile sheep. J Thorac Cardiovasc Surg. 1994 Nov; 108(5):880-7.

135. Weinberg EO, Schoen FJ, George D, Kagaya Y, Douglas PS, Litwin SE, Schunkert H, Benedict CR, Lorell BH. Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis. Circulation. 1994 Sep; 90(3):1410-22.

136. Schappert T, Sadony V, Schoen F, von Birgelen C, Zerkowski HR, Erbel R. Diagnosis and therapeutic consequences of intramural aortic hematoma. J Card Surg. 1994 Sep; 9(5):508-12; discussion 512-5.

137. McKay DB, Milford EL, Carpenter CB, Kartashov AI, Schoen FJ, Loh E, Aranki SF, Couper GS, Mudge GH. T cell activation in cardiac transplant recipients. Transplantation. 1994 Jul 27; 58(2):241-5.

138. Chen W, Schoen FJ, Levy RJ. Mechanism of efficacy of 2-amino oleic acid for inhibition of calcification of glutaraldehyde-pretreated porcine bioprosthetic heart valves. Circulation. 1994 Jul; 90(1):323-9.

139. Winters GL, Hauptman PJ, Jarcho JA, Schoen FJ. Immediate evaluation of endomyocardial biopsies for clinically suspected rejection after heart transplantation. Circulation. 1994 May; 89(5):2079-84.

140. Tanaka H, Sukhova GK, Swanson SJ, Cybulsky MI, Schoen FJ, Libby P. Endothelial and smooth muscle cells express leukocyte adhesion molecules heterogeneously during acute rejection of rabbit cardiac allografts. Am J Pathol. 1994 May; 144(5):938-51.

141. Schoen FJ, Levy RJ. Pathology of substitute heart valves: new concepts and developments. J Card Surg. 1994 Mar; 9(2 Suppl):222-7.

142. Tomazic BB, Brown WE, Schoen FJ. Physicochemical properties of calcific deposits isolated from porcine bioprosthetic heart valves removed from patients following 2-13 years function. J Biomed Mater Res. 1994 Jan; 28(1):35-47.

143. Hirsch D, Drader J, Thomas TJ, Schoen FJ, Levy JT, Levy RJ. Inhibition of calcification of glutaraldehyde pretreated porcine aortic valve cusps with sodium dodecyl sulfate: preincubation and controlled release studies. J Biomed Mater Res. 1993 Dec; 27(12):1477-84.

144. Sellke FW, Friedman M, Dai HB, Shafique T, Schoen FJ, Weintraub RM, Johnson RG. Mechanisms causing coronary microvascular dysfunction following crystalloid cardioplegia and reperfusion. Cardiovasc Res. 1993 Nov; 27(11):1925-32.

145. Hirsch D, Drader J, Pathak YV, Yee R, Schoen FJ, Levy RJ. Synergistic inhibition of the calcification of glutaraldehyde pretreated bovine pericardium in a rat subdermal model by FeCl3 and ethanehydroxydiphosphonate: preincubation and polymeric controlled release studies. Biomaterials. 1993 Jul; 14(9):705-11.

146. Kandarpa K, Jakab P, Patz S, Schoen FJ, Jolesz FA. Prototype miniature endoluminal MR imaging catheter. J Vasc Interv Radiol. 1993 May-Jun; 4(3):419-27.

147. Schunkert H, Jackson B, Tang SS, Schoen FJ, Smits JF, Apstein CS, Lorell BH. Distribution and functional significance of cardiac angiotensin converting enzyme in hypertrophied rat hearts. Circulation. 1993 Apr; 87(4):1328-39.

148. Hirsch D, Schoen FJ, Levy RJ. Effects of metallic ions and diphosphonates on inhibition of pericardial bioprosthetic tissue calcification and associated alkaline phosphatase activity. Biomaterials. 1993 Apr; 14(5):371-7.

149. Sellke FW, Shafique T, Johnson RG, Dai HB, Banitt PF, Schoen FJ, Weintraub RM. Blood and albumin cardioplegia preserve endothelium-dependent microvascular responses. Ann Thorac Surg. 1993 Apr; 55(4):977-85.

150. Lee RT, Loree HM, Cheng GC, Lieberman EH, Jaramillo N, Schoen FJ. Computational structural analysis based on intravascular ultrasound imaging before in vitro angioplasty: prediction of plaque fracture locations. J Am Coll Cardiol. 1993 Mar 1; 21(3):777-82.

151. Banitt PF, Shafique T, Weintraub RM, Johnson RG, Schoen FJ, Sellke FW. Relaxation responses of the coronary microcirculation after cardiopulmonary bypass and ischemic arrest with cardioplegia: implications for the treatment of postoperative coronary spasm. J Cardiothorac Vasc Anesth. 1993 Feb; 7(1):55-60.

152. Sellke FW, Shafique T, Schoen FJ, Weintraub RM. Impaired endothelium-dependent coronary microvascular relaxation after cold potassium cardioplegia and reperfusion. J Thorac Cardiovasc Surg. 1993 Jan; 105(1):52-8.

153. Flomenbaum MA, Schoen FJ. Effects of fixation back pressure and antimineralization treatment on the morphology of porcine aortic bioprosthetic valves. J Thorac Cardiovasc Surg. 1993 Jan; 105(1):154-64.

154. Schoen FJ, Levy RJ, Hilbert SL, Bianco RW. Antimineralization treatments for bioprosthetic heart valves. Assessment of efficacy and safety. J Thorac Cardiovasc Surg. 1992 Nov; 104(5):1285-8.

155. Love JW, Schoen FJ, Breznock EM, Shermer SP, Love CS. Experimental evaluation of an autologous tissue heart valve. J Heart Valve Dis. 1992 Nov; 1(2):232-41.

156. Alameddine AK, Schoen FJ, Yanagi H, Couper GS, Collins JJ, Cohn LH. Aortic or mitral valve replacement in systemic lupus erythematosus. Am J Cardiol. 1992 Oct 1; 70(9):955-6.

157. Treasure CB, Vita JA, Ganz P, Ryan TJ, Schoen FJ, Vekshtein VI, Yeung AC, Mudge GH, Alexander RW, Selwyn AP, et al. Loss of the coronary microvascular response to acetylcholine in cardiac transplant patients. Circulation. 1992 Oct; 86(4):1156-64.

158. Schoen FJ, Golomb G, Levy RJ. Calcification of bioprosthetic heart valves: a perspective on models. J Heart Valve Dis. 1992 Sep; 1(1):110-4.

159. Takahashi T, Allen PD, Lacro RV, Marks AR, Dennis AR, Schoen FJ, Grossman W, Marsh JD, Izumo S. Expression of dihydropyridine receptor (Ca2+ channel) and calsequestrin genes in the myocardium of patients with end-stage heart failure. J Clin Invest. 1992 Sep; 90(3):927-35.

160. Webb CL, Nguyen NM, Schoen FJ, Levy RJ. Calcification of allograft aortic wall in a rat subdermal model. Pathophysiology and inhibition by Al3+ and aminodiphosphonate preincubations. Am J Pathol. 1992 Aug; 141(2):487-96.

161. Connelly CM, Ngoy S, Schoen FJ, Apstein CS. Biomechanical properties of reperfused transmural myocardial infarcts in rabbits during the first week after infarction. Implications for left ventricular rupture. Circ Res. 1992 Aug; 71(2):401-13.

162. McGonagle-Wolff K, Schoen FJ. Morphologic findings in explanted Mitroflow pericardial bioprosthetic valves. Am J Cardiol. 1992 Jul 15; 70(2):263-4.

163. Johnston TP, Webb CL, Schoen FJ, Levy RJ. Assessment of the in vitro transport parameters for ethanehydroxy diphosphonate through a polyurethane membrane. A potential refillable reservoir drug delivery device. ASAIO J. 1992 Jul-Sep; 38(3):M611-6.

164. Sellke FW, Kagaya Y, Johnson RG, Shafique T, Schoen FJ, Grossman W, Weintraub RM. Endothelial modulation of porcine coronary microcirculation perfused via immature collaterals. Am J Physiol. 1992 Jun; 262(6 Pt 2):H1669-75.

165. Kadoba K, Schoen FJ, Jonas RA. Experimental comparison of albumin-sealed and gelatin-sealed knitted Dacron conduits. Porosity control, handling, sealant resorption, and healing. J Thorac Cardiovasc Surg. 1992 Jun; 103(6):1059-67.

166. Libby P, Swanson SJ, Tanaka H, Murray A, Schoen FJ, Pober JS. Immunopathology of coronary arteriosclerosis in transplanted hearts. J Heart Lung Transplant. 1992 May-Jun; 11(3 Pt 2):S5-6.

167. Schoen FJ, Levy RJ. Bioprosthetic heart valve calcification: membrane-mediated events and alkaline phosphatase. Bone Miner. 1992 May; 17(2):129-33.

168. Xia W, Fearon DT, Moore FD, Schoen FJ, Ortiz F, Kirkman RL. Prolongation of guinea pig cardiac xenograft survival in rats by soluble human complement receptor type 1. Transplant Proc. 1992 Apr; 24(2):479-80.

169. Neish AS, Loh E, Schoen FJ. Myocardial changes in cardiac transplant-associated coronary arteriosclerosis: potential for timely diagnosis. J Am Coll Cardiol. 1992 Mar 1; 19(3):586-92.

170. Gott JP. Calcification of porcine valves: a successful new method of antimineralization. Ann Thorac Surg. 1992 Feb; 53(2):207-15; discussion 216.

171. Schoen FJ. The first step to understanding valve failure: an overview of pathology. Eur J Cardiothorac Surg. 1992; 6 Suppl 1:S50-3.

172. Golomb G, Lewinstein I, Ezra V, Schoen FJ. Mechanical properties and histology of charge modified bioprosthetic tissue resistant to calcification. Biomaterials. 1992; 13(6):353-6.

173. Lee RT, Richardson SG, Loree HM, Grodzinsky AJ, Gharib SA, Schoen FJ, Pandian N. Prediction of mechanical properties of human atherosclerotic tissue by high-frequency intravascular ultrasound imaging. An in vitro study. Arterioscler Thromb. 1992 Jan; 12(1):1-5.

174. Schoen FJ, Levy RJ. Heart valve bioprostheses: antimineralization. Eur J Cardiothorac Surg. 1992; 6 Suppl 1:S91-3; discussion S94.

175. Flomenbaum MA, Jarcho JA, Schoen FJ. Progressive multifocal leukoencephalopathy fifty-seven months after heart transplantation. J Heart Lung Transplant. 1991 Nov-Dec; 10(6):888-93.

176. Ridker PM, Schoen FJ. Surgical management of carcinoid heart disease. Ann Thorac Surg. 1991 Nov; 52(5):1208.

177. Levy RJ, Schoen FJ, Anderson HC, Harasaki H, Koch TH, Brown W, Lian JB, Cumming R, Gavin JB. Cardiovascular implant calcification: a survey and update. Biomaterials. 1991 Oct; 12(8):707-14.

178. Rushing L, Schoen FJ, Hirsch A, Lie JT. Granulomatous aortic valvulitis associated with aortic insufficiency in Takayasu aortitis. Hum Pathol. 1991 Oct; 22(10):1050-3.

179. Levy RJ, Schoen FJ, Flowers WB, Staelin ST. Initiation of mineralization in bioprosthetic heart valves: studies of alkaline phosphatase activity and its inhibition by AlCl3 or FeCl3 preincubations. J Biomed Mater Res. 1991 Aug; 25(8):905-35.

180. Schoen FJ, Libby P. Cardiac transplant graft arteriosclerosis. Trends Cardiovasc Med. 1991 Jul-Aug; 1(5):216-23.

181. Masetti P, DiSesa VJ, Schoen FJ, Sun SC, Byrne JG, Appleyard RF, Laurence R, Cohn LH. Ischemic injury before heart transplantation does not cause coronary arteriopathy in experimental isografts. J Heart Lung Transplant. 1991 Jul-Aug; 10(4):597-9.

182. Ridker PM, Chertow GM, Karlson EW, Neish AS, Schoen FJ. Bioprosthetic tricuspid valve stenosis associated with extensive plaque deposition in carcinoid heart disease. Am Heart J. 1991 Jun; 121(6 Pt 1):1835-8.

183. Schoen FJ, Castellot JJ. Vascular graft intimal fibrous hyperplasia: prospects for pharmacological inhibition. J Vasc Surg. 1991 May; 13(5):758-61.

184. Lee RT, Grodzinsky AJ, Frank EH, Kamm RD, Schoen FJ. Structure-dependent dynamic mechanical behavior of fibrous caps from human atherosclerotic plaques. Circulation. 1991 May; 83(5):1764-70.

185. Libby P, Pober JS, Swanson SJ, Mudge GH, Schoen FJ. Arteriosclerosis in transplanted hearts: too much and too soon. Can J Cardiol. 1991 Apr; 7(3):XI-XII.

186. Schoen FJ. Biomaterials science, medical devices, and artificial organs. Synergistic interactions for the 1990s. ASAIO Trans. 1991 Apr-Jun; 37(2):44-8.

187. Salomon RN, Hughes CC, Schoen FJ, Payne DD, Pober JS, Libby P. Human coronary transplantation-associated arteriosclerosis. Evidence for a chronic immune reaction to activated graft endothelial cells. Am J Pathol. 1991 Apr; 138(4):791-8.

188. Webb CL, Schoen FJ, Flowers WE, Alfrey AC, Horton C, Levy RJ. Inhibition of mineralization of glutaraldehyde-pretreated bovine pericardium by AlCl3. Mechanisms and comparisons with FeCl3, LaCl3, and Ga(NO3)3 in rat subdermal model studies. Am J Pathol. 1991 Apr; 138(4):971-81.

189. Gwathmey JK, Warren SE, Briggs GM, Copelas L, Feldman MD, Phillips PJ, Callahan M, Schoen FJ, Grossman W, Morgan JP. Diastolic dysfunction in hypertrophic cardiomyopathy. Effect on active force generation during systole. J Clin Invest. 1991 Mar; 87(3):1023-31.

190. DiSesa VJ, Masetti P, Diaco M, Schoen FJ, Marsh JD, Cohn LH. The mechanism of heart failure caused by cardiac allograft rejection. J Thorac Cardiovasc Surg. 1991 Mar; 101(3):446-9.

191. Briscoe DM, Schoen FJ, Rice GE, Bevilacqua MP, Ganz P, Pober JS. Induced expression of endothelial-leukocyte adhesion molecules in human cardiac allografts. Transplantation. 1991 Feb; 51(2):537-9.

192. Pathak YV, Boyd J, Levy RJ, Schoen FJ. Prevention of calcification of glutaraldehyde pretreated bovine pericardium through controlled release polymeric implants: studies of Fe3+, Al3+, protamine sulphate and levamisole. Biomaterials. 1990 Nov; 11(9):718-23.

193. Lorell BH, Apstein CS, Cunningham MJ, Schoen FJ, Weinberg EO, Peeters GA, Barry WH. Contribution of endothelial cells to calcium-dependent fluorescence transients in rabbit hearts loaded with indo 1. Circ Res. 1990 Aug; 67(2):415-25.

194. Webb CL, Flowers WE, Horton C, Schoen FJ, Levy RJ. Long-term efficacy of Al3+ for prevention of bioprosthetic heart valve calcification. ASAIO Trans. 1990 Jul-Sep; 36(3):M408-10.

195. Miller A, Jepsen SJ, Stonebridge PA, Tsoukas A, Gibbons GW, Pomposelli FB, Freeman DV, Campbell DR, Schoen FJ, LoGerfo FW. New angioscopic findings in graft failure after infrainguinal bypass. Arch Surg. 1990 Jun; 125(6):749-54; discussion 755.

196. Webb CL, Flowers WE, Boyd J, Rosenthal EL, Schoen FJ, Levy RJ. Al+++ binding studies and metallic cation effects on bioprosthetic heart valve calcification in the rat subdermal model. ASAIO Trans. 1990 Apr-Jun; 36(2):56-9.

197. Wang PJ, Schoen FJ, Reagan K, Hasan HH, Guo HS, Friedman PL. Modification of atrioventricular conduction by selective AV nodal artery catheterization. Pacing Clin Electrophysiol. 1990 Jan; 13(1):88-102.

198. Schoen FJ, Anderson JM, Didisheim P, Dobbins JJ, Gristina AG, Harasaki H, Simmons RL. Ventricular assist device (VAD) pathology analyses: guidelines for clinical studies. J Appl Biomater. 1990; 1(1):49-56.

199. Phillips PJ, Gwathmey JK, Feldman MD, Schoen FJ, Grossman W, Morgan JP. Post-extrasystolic potentiation and the force-frequency relationship: differential augmentation of myocardial contractility in working myocardium from patients with end-stage heart failure. J Mol Cell Cardiol. 1990 Jan; 22(1):99-110.

200. Sherry B, Schoen FJ, Wenske E, Fields BN. Derivation and characterization of an efficiently myocarditic reovirus variant. J Virol. 1989 Nov; 63(11):4840-9.

201. Libby P, Salomon RN, Payne DD, Schoen FJ, Pober JS. Functions of vascular wall cells related to development of transplantation-associated coronary arteriosclerosis. Transplant Proc. 1989 Aug; 21(4):3677-84.

202. Miller A, Lipson WE, Isaacsohn JL, Schoen FJ, Lees RS. Intraoperative angioscopy: principles of irrigation and description of a new dedicated irrigation pump. Am Heart J. 1989 Aug; 118(2):391-9.

203. Treasure CB, Schoen FJ, Treseler PA, Bittl JA. Leaflet entrapment causing acute severe aortic insufficiency during balloon aortic valvuloplasty. Clin Cardiol. 1989 Jul; 12(7):405-8.

204. Webb CL, Schoen FJ, Levy RJ. Covalent binding of aminopropanehydroxydiphosphonate to glutaraldehyde residues in pericardial bioprosthetic tissue: stability and calcification inhibition studies. Exp Mol Pathol. 1989 Jun; 50(3):291-302.

205. Loh E, Rabbani LE, Lee RT, Couper GS, Schoen FJ. Giant right atrial LeVeen shunt pseudocyst. Am J Cardiol. 1989 May 15; 63(17):1289-90.

206. Jenkins RD, Sinclair IN, Leonard BM, Sandor T, Schoen FJ, Spears JR. Laser balloon angioplasty versus balloon angioplasty in normal rabbit iliac arteries. Lasers Surg Med. 1989; 9(3):237-47.

207. Sands KE, Appel ML, Lilly LS, Schoen FJ, Mudge GH, Cohen RJ. Power spectrum analysis of heart rate variability in human cardiac transplant recipients. Circulation. 1989 Jan; 79(1):76-82.

208. Didisheim P, Olsen DB, Farrar DJ, Portner PM, Griffith BP, Pennington DG, Joist JH, Schoen FJ, Gristina AG, Anderson JM. Infections and thromboembolism with implantable cardiovascular devices. ASAIO Trans. 1989 Jan-Mar; 35(1):54-70.

209. Waldman JD, Lamberti JJ, Schoen FJ, George L, Kirkpatrick SE, Mathewson JW, Spicer RL, Grehl TM, Goodman AH. Balloon dilatation of stenotic right ventricle-to-pulmonary artery conduits. J Card Surg. 1988 Dec; 3(4):539-46.

210. Zimmermann B, Lally EV, Sharma SC, Schoen FJ, Kaplan SR. Severe aortic stenosis in systemic lupus erythematosus and mucopolysaccharidosis type II (Hunter's syndrome). Clin Cardiol. 1988 Oct; 11(10):723-5.

211. Maranto AR, Schoen FJ. Alkaline phosphatase activity of glutaraldehyde-treated bovine pericardium used in bioprosthetic cardiac valves. Circ Res. 1988 Oct; 63(4):844-8.

212. Schoen FJ. The future of bioprosthetic valves. A pathologist's perspective. ASAIO Trans. 1988 Oct-Dec; 34(4):1040-2.

213. Lees AM, Lees RS, Schoen FJ, Isaacsohn JL, Fischman AJ, McKusick KA, Strauss HW. Imaging human atherosclerosis with 99mTc-labeled low density lipoproteins. Arteriosclerosis. 1988 Sep-Oct; 8(5):461-70.

214. Webb CL, Benedict JJ, Schoen FJ, Linden JA, Levy RJ. Inhibition of bioprosthetic heart valve calcification with aminodiphosphonate covalently bound to residual aldehyde groups. Ann Thorac Surg. 1988 Sep; 46(3):309-16.

215. Tsao JW, Schoen FJ, Shankar R, Sallis JD, Levy RJ. Retardation of calcification of bovine pericardium used in bioprosthetic heart valves by phosphocitrate and a synthetic analogue. Biomaterials. 1988 Sep; 9(5):393-7.

216. Maranto AR, Schoen FJ. Effect of delay between tissue harvest and glutaraldehyde pretreatment on mineralization of bovine pericardium used in bioprosthetic heart valves. J Biomed Mater Res. 1988 Sep; 22(9):819-25.

217. Johnston TP, Schoen FJ, Levy RJ. Prevention of calcification of bioprosthetic heart valve leaflets by Ca2+ diphosphonate pretreatment. J Pharm Sci. 1988 Sep; 77(9):740-4.

218. Maranto AR, Schoen FJ. Phosphatase enzyme activity is retained in glutaraldehyde treated bioprosthetic heart valves. ASAIO Trans. 1988 Jul-Sep; 34(3):827-30.

219. Webb CL, Phelps LL, Schoen FJ, Levy RJ. Aminodiphosphonate or AI preincubation inhibits calcification of aortic homografts in the rat subdermal model. ASAIO Trans. 1988 Jul-Sep; 34(3):851-4.

220. Johnston TP, Bove EL, Bolling SF, Schoen FJ, Boyd JA, Golomb G, Levy RJ. Local controlled release of 1-hydroxyethylidene diphosphonate using silicone-rubber matrices. Effects of sterilization on in vitro release and in vivo efficacy. ASAIO Trans. 1988 Jul-Sep; 34(3):835-8.

221. Webb CL, Schoen FJ, Levy RJ. AL preincubation inhibits calcification of bioprosthetic heart valve tissue in the rat subdermal model. ASAIO Trans. 1988 Jul-Sep; 34(3):855-9.

222. Polak JF, Vivaldi MT, Schoen FJ. Proton magnetic resonance of early myocardial infarction in rats. Invest Radiol. 1988 Jun; 23(6):428-32.

223. Davies PF, Olesen SP, Clapham DE, Morrel EM, Schoen FJ. Endothelial communication. State of the art lecture. Hypertension. 1988 Jun; 11(6 Pt 2):563-72.

224. Shemin RJ, Schoen FJ, Hein R, Austin J, Cohn LH. Hemodynamic and pathologic evaluation of a unileaflet pericardial bioprosthetic valve. J Thorac Cardiovasc Surg. 1988 May; 95(5):912-9.

225. Prince MR, Salzman EW, Schoen FJ, Palestrant AM, Simon M. Local intravascular effects of the nitinol wire blood clot filter. Invest Radiol. 1988 Apr; 23(4):294-300.

226. Schoen FJ, Harasaki H, Kim KM, Anderson HC, Levy RJ. Biomaterial-associated calcification: pathology, mechanisms, and strategies for prevention. J Biomed Mater Res. 1988 Apr; 22(A1 Suppl):11-36.

227. Jonas RA, Ziemer G, Schoen FJ, Britton L, Castaneda AR. A new sealant for knitted Dacron prostheses: minimally cross-linked gelatin. J Vasc Surg. 1988 Mar; 7(3):414-9.

228. Austin JC, Berrizbeitia LD, Schoen FJ, Kauffman RP, Hechtman HB, Cohn LH. Thromboxane synthetase inhibition reduces ventricular irritability after coronary occlusion and reperfusion. Am Heart J. 1988 Mar; 115(3):505-9.

229. Schoen FJ, Kujovich JL, Levy RJ, Sutton MS. Bioprosthetic valve failure. Cardiovasc Clin. 1988; 18(2):289-317.

230. Fish RD, Nabel EG, Selwyn AP, Ludmer PL, Mudge GH, Kirshenbaum JM, Schoen FJ, Alexander RW, Ganz P. Responses of coronary arteries of cardiac transplant patients to acetylcholine. J Clin Invest. 1988 Jan; 81(1):21-31.

231. Liang BT, Antman EM, Taus R, Collins JJ, Schoen FJ. Atherosclerotic aneurysms of aortocoronary vein grafts. Am J Cardiol. 1988 Jan 1; 61(1):185-8.

232. Jenkins RD, Sinclair IN, Anand R, Kalil AG, Schoen FJ, Spears JR. Laser balloon angioplasty: effect of tissue temperature on weld strength of human postmortem intima-media separations. Lasers Surg Med. 1988; 8(1):30-9.

233. Schoen FJ, Kujovich JL, Webb CL, Levy RJ. Chemically determined mineral content of explanted porcine aortic valve bioprostheses: correlation with radiographic assessment of calcification and clinical data. Circulation. 1987 Nov; 76(5):1061-6.

234. Schoen FJ, Clagett GP, Hill JD, Chenoweth DE, Anderson JM, Eberhart RC. The biocompatibility of artificial organs. ASAIO Trans. 1987 Oct-Dec; 33(4):824-33.

235. Levy RJ, Schoen FJ, Lund SA, Smith MS. Prevention of leaflet calcification of bioprosthetic heart valves with diphosphonate injection therapy. Experimental studies of optimal dosages and therapeutic durations. J Thorac Cardiovasc Surg. 1987 Oct; 94(4):551-7.

236. Jonas RA, Schoen FJ, Ziemer G, Britton L, Castaneda AR. Biological sealants and knitted Dacron conduits: comparison of collagen and fibrin glue pretreatments in circulatory models. Ann Thorac Surg. 1987 Sep; 44(3):283-90.

237. Schoen FJ. Cardiac pathology in asthma. J Allergy Clin Immunol. 1987 Sep; 80(3 Pt 2):419-23.

238. Isoyama S, Wei JY, Izumo S, Fort P, Schoen FJ, Grossman W. Effect of age on the development of cardiac hypertrophy produced by aortic constriction in the rat. Circ Res. 1987 Sep; 61(3):337-45.

239. Schoen FJ, Fernandez J, Gonzalez-Lavin L, Cernaianu A. Causes of failure and pathologic findings in surgically removed Ionescu-Shiley standard bovine pericardial heart valve bioprostheses: emphasis on progressive structural deterioration. Circulation. 1987 Sep; 76(3):618-27.

240. Madras PN, Schoen FJ, Clayson SE, Bolduc M, Simpson MA, O'Hara CJ. Stress-related subintimal hyperplasia. Transplant Proc. 1987 Aug; 19(4 Suppl 5):36-41.

241. Schnitt SJ, Ciano PS, Schoen FJ. Quantitation of lymphocytes in endomyocardial biopsies: use and limitations of antibodies to leukocyte common antigen. Hum Pathol. 1987 Aug; 18(8):796-800.

242. Vivaldi MT, Eyre DR, Kloner RA, Schoen FJ. Effects of methylprednisolone on collagen biosynthesis in healing acute myocardial infarction. Am J Cardiol. 1987 Aug 1; 60(4):424-5.

243. Waldman JD, Schoen FJ, Kirkpatrick SE, Mathewson JW, George L, Lamberti JJ. Balloon dilatation of porcine bioprosthetic valves in the pulmonary position. Circulation. 1987 Jul; 76(1):109-14.

244. Gwathmey JK, Copelas L, MacKinnon R, Schoen FJ, Feldman MD, Grossman W, Morgan JP. Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. Circ Res. 1987 Jul; 61(1):70-6.

245. Webb CL, Benedict JJ, Schoen FJ, Linden JA, Levy RJ. Inhibition of bioprosthetic heart valve calcification with covalently bound aminopropanehydroxydiphosphonate. ASAIO Trans. 1987 Jul-Sep; 33(3):592-5.

246. Miller A, Schoen FJ, Lees AM, Fallon JT, Strauss HW, Lees RS. Low density lipoprotein accumulation by PTFE grafts in the rabbit aorta. Autoradiographic-morphologic correlations. ASAIO Trans. 1987 Jul-Sep; 33(3):489-93.

247. Schoen FJ. Surgical pathology of removed natural and prosthetic heart valves. Hum Pathol. 1987 Jun; 18(6):558-67.

248. Schoen FJ, Sutton MS. Contemporary issues in the pathology of valvular heart disease. Hum Pathol. 1987 Jun; 18(6):568-76.

249. Arnold JM, Antman EM, Przyklenk K, Braunwald E, Sandor T, Vivaldi MT, Schoen FJ, Kloner RA. Differential effects of reperfusion on incidence of ventricular arrhythmias and recovery of ventricular function at 4 days following coronary occlusion. Am Heart J. 1987 May; 113(5):1055-65.

250. Golomb G, Schoen FJ, Smith MS, Linden J, Dixon M, Levy RJ. The role of glutaraldehyde-induced cross-links in calcification of bovine pericardium used in cardiac valve bioprostheses. Am J Pathol. 1987 Apr; 127(1):122-30.

251. Golomb G, Dixon M, Smith MS, Schoen FJ, Levy RJ. Controlled-release drug delivery of diphosphonates to inhibit bioprosthetic heart valve calcification: release rate modulation with silicone matrices via drug solubility and membrane coating. J Pharm Sci. 1987 Apr; 76(4):271-6.

252. Schoen FJ. Cardiac valve prostheses: review of clinical status and contemporary biomaterials issues. J Biomed Mater Res. 1987 Apr; 21(A1 Suppl):91-117.

253. Schoen FJ. Cardiac valve prostheses: pathological and bioengineering considerations. J Card Surg. 1987 Mar; 2(1):65-108.

254. Cunningham MJ, Rothenberg PL, Schatten S, Schur PH, Schoen FJ. Infected acute myocardial infarct with rupture in systemic lupus erythematosus. Am J Cardiol. 1987 Feb 15; 59(5):488-9.

255. Drislane FW, Samuels MA, Kozakewich H, Schoen FJ, Strunk RC. Myocardial contraction band lesions in patients with fatal asthma: possible neurocardiologic mechanisms. Am Rev Respir Dis. 1987 Feb; 135(2):498-501.

256. Feldman MD, Copelas L, Gwathmey JK, Phillips P, Warren SE, Schoen FJ, Grossman W, Morgan JP. Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure. Circulation. 1987 Feb; 75(2):331-9.

257. Schoen FJ. Biomaterial-associated infection, neoplasia, and calcification. Clinicopathologic features and pathophysiologic concepts. ASAIO Trans. 1987 Jan-Mar; 33(1):8-18.

258. Aretz HT, Billingham ME, Edwards WD, Factor SM, Fallon JT, Fenoglio JJ, Olsen EG, Schoen FJ. Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol. 1987 Jan; 1(1):3-14.

259. Schoen FJ, Palmer DC, Bernhard WF, Pennington DG, Haudenschild CC, Ratliff NB, Berger RL, Golding LR, Watson JT. Clinical temporary ventricular assist. Pathologic findings and their implications in a multi-institutional study of 41 patients. J Thorac Cardiovasc Surg. 1986 Dec; 92(6):1071-81.

260. Golomb G, Dixon M, Smith MS, Schoen FJ, Levy RJ. Inhibition of bioprosthetic heart valve calcification by sustained local delivery of Ca and Na diphosphonate via controlled release matrices. ASAIO Trans. 1986 Jul-Sep; 32(1):587-90.

261. Schoen FJ, Kintanar EB, Osol RG, Lee E. Pulmonary reaction to intravenously injected polymer beads. J Biomed Mater Res. 1986 Jul-Aug; 20(6):709-21.

262. Jonas RA, Schoen FJ, Levy RJ, Castaneda AR. Biological sealants and knitted Dacron: porosity and histological comparisons of vascular graft materials with and without collagen and fibrin glue pretreatments. Ann Thorac Surg. 1986 Jun; 41(6):657-63.

263. Przyklenk K, Vivaldi MT, Schoen FJ, Malcolm J, Arnold O, Kloner RA. Salvage of ischaemic myocardium by reperfusion: importance of collateral blood flow and myocardial oxygen demand during occlusion. Cardiovasc Res. 1986 Jun; 20(6):403-14.

264. Bloomfield P, Schoen FJ, Force T, Khuri S, Parisi AF. Calcified left atrial mass associated with mitral valve prolapse. Am Heart J. 1986 Jun; 111(6):1205-7.

265. Stone JJ, Piccione W, Berrizbeitia LD, Dance GR, Schoen FJ, Shemin RJ, Cohn LH. Hemodynamic, metabolic, and morphological effects of cardiopulmonary bypass with a fluorocarbon priming solution. Ann Thorac Surg. 1986 Apr; 41(4):419-24.

266. Schoen FJ, Tsao JW, Levy RJ. Calcification of bovine pericardium used in cardiac valve bioprostheses. Implications for the mechanisms of bioprosthetic tissue mineralization. Am J Pathol. 1986 Apr; 123(1):134-45.

267. Coleman SE, Hood CI, Schoen FJ, Rheinhardt JM. Evaluation of anti-inflammatory agents using a model of granuloma formation evoked by divinyl copolymer beads in the mouse lung. J Biomed Mater Res. 1986 Mar; 20(3):301-14.

268. Levy RJ, Schoen FJ, Sherman FS, Nichols J, Hawley MA, Lund SA. Calcification of subcutaneously implanted type I collagen sponges. Effects of formaldehyde and glutaraldehyde pretreatments. Am J Pathol. 1986 Jan; 122(1):71-82.

269. Przyklenk K, Vivaldi MT, Arnold JM, Schoen FJ, Kloner RA. Capillary anastomoses between the left anterior descending and circumflex circulations in the canine heart: possible importance during coronary artery occlusion. Microvasc Res. 1986 Jan; 31(1):54-65.

270. Vivaldi MT, Kloner RA, Schoen FJ. Triphenyltetrazolium staining of irreversible ischemic injury following coronary artery occlusion in rats. Am J Pathol. 1985 Dec; 121(3):522-30.

271. Kirkman RL, Barrett LV, Gaulton GN, Kelley VE, Koltun WA, Schoen FJ, Ythier A, Strom TB. The effect of anti-interleukin-2 receptor monoclonal antibody on allograft rejection. Transplantation. 1985 Dec; 40(6):719-22.

272. Hiehle JF, Bourgelais DB, Shapshay S, Schoen FJ, Kim D, Spears R. Nd-YAG laser fusion of human atheromatous plaque-arterial wall separations in vitro. Am J Cardiol. 1985 Dec 1; 56(15):953-7.

273. Shemin RJ, Marsh JD, Schoen FJ. Benign intracardiac thyroid mass causing right ventricular outflow tract obstruction. Am J Cardiol. 1985 Nov 1; 56(12):828-9.

274. Kirshenbaum JM, Lorell BH, Schoen FJ, Bettmann MA, Thompson GB. Angioinvasive pulmonary aspergillosis: presentation as massive pulmonary saddle embolism in an immunocompromised patient. J Am Coll Cardiol. 1985 Aug; 6(2):486-9.

275. Schoen FJ, Schulman LJ, Cohn LH. Quantitative anatomic analysis of "stent creep" of explanted Hancock standard porcine bioprostheses used for cardiac valve replacement. Am J Cardiol. 1985 Jul 1; 56(1):110-4.

276. Schoen FJ, Hobson CE. Anatomic analysis of removed prosthetic heart valves: causes of failure of 33 mechanical valves and 58 bioprostheses, 1980 to 1983. Hum Pathol. 1985 Jun; 16(6):549-59.

277. Schoen FJ, Levy RJ, Nelson AC, Bernhard WF, Nashef A, Hawley M. Onset and progression of experimental bioprosthetic heart valve calcification. Lab Invest. 1985 May; 52(5):523-32.

278. Levy RJ, Wolfrum J, Schoen FJ, Hawley MA, Lund SA, Langer R. Inhibition of calcification of bioprosthetic heart valves by local controlled-release diphosphonate. Science. 1985 Apr 12; 228(4696):190-2.

279. Hammerman H, Kloner RA, Alker KJ, Schoen FJ, Braunwald E. Effects of transient increased afterload during experimentally induced acute myocardial infarction in dogs. Am J Cardiol. 1985 Feb 15; 55(5):566-70.

280. Levy RJ, Hawley MA, Schoen FJ, Lund SA, Liu PY. Inhibition by diphosphonate compounds of calcification of porcine bioprosthetic heart valve cusps implanted subcutaneously in rats. Circulation. 1985 Feb; 71(2):349-56.

281. Bernhard WF, Clay W, Gernes D, Hougen T, Sherman C, Burke D, Schoen FJ, Poirier VL. Temporary and permanent left ventricular bypass: laboratory and clinical observations. World J Surg. 1985 Feb; 9(1):54-64.

282. Levy RJ, Golomb G, Wolfrum J, Lund SA, Schoen FJ, Langer R. Local controlled-release of diphosphonates from ethylenevinylacetate matrices prevents bioprosthetic heart valve calcification. Trans Am Soc Artif Intern Organs. 1985; 31:459-63.

283. Schoen FJ, Palmer DC, Haudenschild CC, Ratliff NB, Watson JT. Pathologic findings and their implications in patients managed with temporary ventricular assist. Trans Am Soc Artif Intern Organs. 1985; 31:66-72.

284. Tryka AF, Godleski JJ, Schoen FJ, Vandevanter SH. Pulmonary vascular disease and hypertension after valve surgery for mitral stenosis. Hum Pathol. 1985 Jan; 16(1):65-71.

285. Nelson AC, Schoen FJ, Levy RJ. Scanning electron microscopy methodology for study of the pathophysiology of calcification in bioprosthetic heart valves. Scan Electron Microsc. 1985; (Pt 1):209-13.

286. Abdulali SA, Silverton NP, Schoen FJ, Saunders NR, Ionescu MI. Late outcome of patients with Braunwald-Cutter mitral valve replacement. Ann Thorac Surg. 1984 Dec; 38(6):579-85.

287. Schoen FJ, Berger BM, Guerina NG. Cardiac effects of noncardiac neoplasms. Cardiol Clin. 1984 Nov; 2(4):657-70.

288. Hood CI, Schoen FJ, Coleman SE, Mickley LD. Assessment of tissue reactions to biomaterials: a model system using the foreign body response in the mouse lung to intravenously injected divinyl copolymer beads. J Biomed Mater Res. 1984 Nov-Dec; 18(9):1031-41.

289. Muller WA, Cohn LH, Schoen FJ. Infection within a degenerated Starr-Edwards silicone rubber poppet in the aortic valve position. Am J Cardiol. 1984 Nov 1; 54(8):1146.

290. Schoen FJ, Levy RJ. Bioprosthetic heart valve failure: pathology and pathogenesis. Cardiol Clin. 1984 Nov; 2(4):717-39.

291. Schoen FJ, Lawrie GM, Titus JL. Left ventricular cellular hypertrophy in pressure- and volume-overload valvular heart disease. Hum Pathol. 1984 Sep; 15(9):860-5.

292. Schoen FJ, Goodenough SH, Ionescu MI, Braunwald NS. Implications of late morphology of Braunwald-Cutter mitral heart valve prostheses. J Thorac Cardiovasc Surg. 1984 Aug; 88(2):208-16.

293. Bernhard WF, Gernes DG, Clay WC, Schoen FJ, Burgeson R, Valeri RC, Melaragno AJ, Poirier VL. Investigations with an implantable, electrically actuated ventricular assist device. J Thorac Cardiovasc Surg. 1984 Jul; 88(1):11-21.

294. Pomposelli F, Schoen F, Cohen R, O'Leary D, Johnson WR, Madras PN. Conformational stress and anastomotic hyperplasia. J Vasc Surg. 1984 Jul; 1(4):525-35.

295. Rabson AB, Schoen FJ, Warhol MJ, Mudge GH, Collins JJ. Giant cell myocarditis after mitral valve replacement: case report and studies of the nature of giant cells. Hum Pathol. 1984 Jun; 15(6):585-7.

296. Hammerman H, Schoen FJ, Braunwald E, Kloner RA. Drug-induced expansion of infarct: morphologic and functional correlations. Circulation. 1984 Mar; 69(3):611-7.

297. Rippe JM, Curley F, Paraskos JA, Schoen FJ, Cohn LH, Alpert JS. Triple-valve endocarditis with unusual echocardiographic findings. Am Heart J. 1984 Mar; 107(3):598-605.

298. Hammerman H, Alker KJ, Schoen FJ, Kloner RA. Morphologic and functional effects of piroxicam on myocardial scar formation after coronary occlusion in dogs. Am J Cardiol. 1984 Feb 1; 53(4):604-7.

299. Sherman FS, Schoen FJ, Hawley MA, Nichols J, Levy RJ. Collagen crosslinks: a critical determinant of bioprosthetic heart valve calcification. Trans Am Soc Artif Intern Organs. 1984; 30:577-81.

300. Hickey WF, Sommerville LH, Schoen FJ. Disseminated Candida glabrata: report of a uniquely severe infection and a literature review. Am J Clin Pathol. 1983 Nov; 80(5):724-7.

301. Levy RJ, Schoen FJ, Levy JT, Nelson AC, Howard SL, Oshry LJ. Biologic determinants of dystrophic calcification and osteocalcin deposition in glutaraldehyde-preserved porcine aortic valve leaflets implanted subcutaneously in rats. Am J Pathol. 1983 Nov; 113(2):143-55.

302. Hammerman H, Schoen FJ, Kloner RA. Short-term exercise has a prolonged effect on scar formation after experimental acute myocardial infarction. J Am Coll Cardiol. 1983 Nov; 2(5):979-82.

303. Levy RJ, Schoen FJ, Howard SL. Mechanism of calcification of porcine bioprosthetic aortic valve cusps: role of T-lymphocytes. Am J Cardiol. 1983 Sep 1; 52(5):629-31.

304. Roberts CS, Schoen FJ, Kloner RA. Effect of coronary reperfusion on myocardial hemorrhage and infarct healing. Am J Cardiol. 1983 Sep 1; 52(5):610-4.

305. Hammerman H, Kloner RA, Hale S, Schoen FJ, Braunwald E. Dose-dependent effects of short-term methylprednisolone on myocardial infarct extent, scar formation, and ventricular function. Circulation. 1983 Aug; 68(2):446-52.

306. Schoen FJ, Braunwald NS. Key references in biomaterials: heart valve replacement. J Biomed Mater Res. 1983 Jul; 17(4):715-29.

307. Hammerman H, Kloner RA, Schoen FJ, Brown EJ, Hale S, Braunwald E. Indomethacin-induced scar thinning after experimental myocardial infarction. Circulation. 1983 Jun; 67(6):1290-5.

308. Collins T, Schoen FJ, Mudge GH, Collins JJ. Thrombosis associated with a porcine bioprosthesis and ascending aortic graft in a patient with the Marfan syndrome. J Thorac Cardiovasc Surg. 1983 May; 85(5):794-6.

309. Schoen FJ, Collins JJ, Cohn LH. Long-term failure rate and morphologic correlations in porcine bioprosthetic heart valves. Am J Cardiol. 1983 Mar 15; 51(6):957-64.

310. Brown EJ, Kloner RA, Schoen FJ, Hammerman H, Hale S, Braunwald E. Scar thinning due to ibuprofen administration after experimental myocardial infarction. Am J Cardiol. 1983 Mar 1; 51(5):877-83.

311. Schoen FJ, Titus JL, Lawrie GM. Autopsy-determined causes of death after cardiac valve replacement. JAMA. 1983 Feb 18; 249(7):899-902.

312. Schoen FJ, Goodenough SH, Ionescu MI, Braunwald NS. Clinicomorphologic correlations following long-term implantation of cloth-covered prosthetic heart valves: implications for device development. Trans Am Soc Artif Intern Organs. 1983; 29:556-62.

313. Colucci WS, Lorell BH, Schoen FJ, Warhol MJ, Grossman W. Hypertrophic obstructive cardiomyopathy due to Fabry's disease. N Engl J Med. 1982 Oct 7; 307(15):926-8.

314. Parisi AF, Nieminen M, O'Boyle JE, Moynihan PF, Khuri SF, Kloner RA, Folland ED, Schoen FJ. Enhanced detection of the evolution of tissue changes after acute myocardial infarction using color-encoded two-dimensional echocardiography. Circulation. 1982 Oct; 66(4):764-70.

315. Schoen FJ, Titus JL, Lawrie GM. Durability of pyrolytic carbon-containing heart valve prostheses. J Biomed Mater Res. 1982 Sep; 16(5):559-70.

316. Schoen FJ, Bernhard WF, Khuri SF, Koster JK, Van Devanter SJ, Weintraub RM. Pathologic findings in postcardiotomy patients managed with a temporary left ventricular assist pump. Am J Surg. 1982 Apr; 143(4):508-14.

317. Schoen FJ, Titus JL, Lawrie GM. Bioengineering aspects of heart valve replacement. Ann Biomed Eng. 1982; 10(3):97-128.

318. Wilson J, Pigott GH, Schoen FJ, Hench LL. Toxicology and biocompatibility of bioglasses. J Biomed Mater Res. 1981 Nov; 15(6):805-17.

319. Hausner RJ, Schoen FJ, Mendez-Fernandez MA, Henly WS, Geis RC. Migration of silicone gel to axillary lymph nodes after prosthetic mammoplasty. Arch Pathol Lab Med. 1981 Jul; 105(7):371-2.

320. Schoen FJ, Hausner RJ, Howell JF, Beazley HL, Titus JL. Porcine heterograft valve replacement in carcinoid heart disease. J Thorac Cardiovasc Surg. 1981 Jan; 81(1):100-5.

321. Schoen FJ, Alexander RW, Hood CI, Dunn LJ. Nodular pulmonary amyloidosis. Description of a case with ultrastructure. Arch Pathol Lab Med. 1980 Feb; 104(2):66-9.

322. Schoen FJ, Normann SJ, Brunswick RA, Diacoff GR. Can a small blood vessel prosthesis be derived from heterologous foreign body reactive tissue? J Biomed Mater Res. 1979 Jan; 13(1):149-54.

323. Shim HS, Schoen FJ. The wear resistance of pure and silicon-alloyed isotropic carbons. Biomater Med Devices Artif Organs. 1974; 2(1):103-18.

324. Schoen FJ, DeLaria GA, Bernstein EF. Morphology of blood-surface interaction on intra-aortic balloons. An analysis of clinical and experimental specimens by scanning electron microscopy. J Thorac Cardiovasc Surg. 1973 Feb; 65(2):304-14.


Send Feedback to the BWH Biomedical Research Institute.

Quick Links Find a Researcher Home
EDIT YOUR PROFILE

Related Links

Department
  • View all Research Faculty in the Department of Pathology
BRI Research Center/Program Affiliation(s)
  • Cancer Research Center
  • Cardiovascular, Diabetes and Metabolic Disorders Research Center
  • Center for Human Genetics
  • Infectious and Immunologic Diseases Research Center
  • Musculoskeletal Research Center
  • Regenerative Therapeutics (RegenRX) Research Center
  • Technology Innovation Program


 

 

Harvard Medical School logo Partners Healthcare logo
CONTACT US DISCLAIMER DIRECTIONS GIVING PRIVACY SITE MAP
© BWH 2010 75 Francis St., Boston, MA 02115 617-732-5500